Drug Profile
Research programme: oxazolidinone antibacterials - Shionogi
Alternative Names: ITU 5002Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Shionogi
- Class Oxazolidinones
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Enterococcal infections; Staphylococcal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Enterococcal-infections in Japan (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Staphylococcal-infections in Japan (PO)
- 20 Sep 2011 Preclinical trials in Enterococcal infections in Japan (PO)